Document is current
Any future updates will be listed below
-
Authors
Cobo-Vuilleumier, Nadia
Lorenzo, Petra I.
Rodríguez, Noelia García
Herrera Gómez, Irene de Gracia
Fuente-Martin, Esther
López-Noriega, Livia
Mellado-Gil, José Manuel
Romero-Zerbo, Silvana-Yanina
Baquié, Mathurin
Lachaud, Christian Claude
Stifter, Katja
Perdomo, German
Bugliani, Marco
De Tata, Vincenzo
Bosco, Domenico
Parnaud, Geraldine
Pozo, David https://orcid.org/0000-0002-3732-4960
Hmadcha, Abdelkrim https://orcid.org/0000-0002-4105-3702
Florido, Javier P.
Toscano, Miguel G.
de Haan, Peter
Schoonjans, Kristina
Sánchez Palazón, Luis
Marchetti, Piero
Schirmbeck, Reinhold
Martín-Montalvo, Alejandro
Meda, Paolo
Soria, Bernat
Bermúdez-Silva, Francisco-Javier https://orcid.org/0000-0003-3133-9691
St-Onge, Luc
Gauthier, Benoit R. https://orcid.org/0000-0001-8146-7486
- License Information
-
More Information
Article History
Received: 10 November 2017
Accepted: 23 March 2018
First Online: 16 April 2018
Competing interests
: Two patents (WO 2011 144725 A2 and WO 2016 156531 A1) related to BL001 have been published, of which B.R.G., N.C.V., D.P., L.S.O., and M.B. are inventors. These patents have been licensed to ARIDDAD Therapeutics, a Biotech spinoff co-founded by B.R.G., N.C.V., L.St.-O., and P.dH. The remaining authors declare no competing interests.
